{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof", "item": "https://www.patentleaderboard.com/patent/9610327"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof

Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof

US Patent 9610327 · Granted Apr 4, 2017

Estimated economic value: $276,197,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineering of an antibody for tumor-selective binding of CD472025
Administration of an anti-activin-a compound to a subject2025
Administration of an anti-activin-a compound to a subject2025
Conversational interface for content creation and editing using large language m2025
Intermediate blank connection system for hot-rolled strip headless rolling and c2025
Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB 2025
SIRP-α binding proteins and methods of use thereof2024
Siglec-9 ECD fusion molecules2024
Conversational interface for content creation and editing using large language m2024
Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases2024
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants2023
Stabilized receptor polypeptides and uses thereof2023